As indispensable additives in the food industry, sweeteners have evolved through the human pursuit of a balanced diet and flavor. From early sucrose substitutes to today's novel sweeteners based on microbial synthesis and molecular design, sweetener research has consistently centered on safety, metabolic properties, and functional expansion. In recent years, with advances in nutritional science, synthetic biology, and consumer health awareness, the sweetener field has shown a significant trend toward technological diversification and precision application.
Reevaluation and Optimization of Traditional Sweeteners
Artificial sweeteners (such as aspartame, saccharin, and sucralose) were once a mainstay of sugar reduction initiatives due to their high sweetness (typically hundreds to thousands of times that of sucrose) and zero-calorie properties. However, controversies since the late 20th century-including concerns about potential carcinogenicity (such as the hypothesized neurotoxicity of aspartame) and its potential to disrupt gut microbiota-have prompted in-depth research into their long-term effects. For example, an animal study published in Nature Metabolism in 2023 suggested that high-dose sucralose may impair satiety signaling by inhibiting intestinal GLP-1 secretion. This finding has prompted some countries to review their acceptable daily intake (ADI). Meanwhile, naturally derived steviol glycosides (extracted from stevia) and mogrosides have gained popularity due to their low side effects. However, due to their subsequent bitterness and processing stability, researchers are optimizing their flavor profiles through enzymatic modification (such as β-glucosidase hydrolysis) and developing compounding techniques (such as synergistically with erythritol) to improve taste.
Breakthroughs in the Biosynthesis of Functional Sweeteners
Synthetic biology provides green and efficient solutions for sweetener production. Taking erythritol as an example, traditional chemical catalysis relies on non-renewable resources and produces numerous byproducts. However, by genetically engineering Escherichia coli or yeast strains to efficiently express phosphoenolpyruvate carboxylase (PEPC) and erythrose reductase (ER), it can be directly fermented from glucose, with conversion rates exceeding 80% (data from Metabolic Engineering, 2022). Even more revolutionary is the development of rare sugars such as allulose: this naturally occurring ketohexose has a sweetness similar to sucrose but only one-tenth the calories, and can be obtained by targeted conversion of fructose using α-glucose isomerase. Japanese researchers have recently achieved large-scale production using immobilized enzyme reactor technology. Its insulin-independent metabolic properties make it a popular choice for diabetic supplements.
Research on Sweetness Perception Mechanisms and Personalized Applications
Modern neuroscience has revealed differences in the distribution of sweet taste receptors (T1R2/T1R3 dimers) in the mouth and intestine, providing a theoretical basis for targeted regulation. Research has shown that certain sweeteners (such as neotame) not only activate oral sweet taste receptors but also influence the hypothalamic feeding center through vagal nerve signaling. Artificial sweeteners, such as saccharin, may desensitize receptors, leading to a subsequent increased preference for sucrose. In response to this, food engineers are designing "dynamic sweetening systems"-for example, using microencapsulation technology to control the release rate of sweeteners and mimic the gradual sweetness curve of sucrose. Nutritionists are advocating for customized sweetening solutions based on individual gut microbiome profiles (for example, the abundance of Firmicutes is correlated with sweetener metabolic efficiency). This signals a shift in sweetener application from "general sugar reduction" to "precision nutrition."
Challenges and Future Directions
Current sweetener research still faces multiple challenges: the lack of long-term human trial data may lead to exaggerated efficacy or underestimated risks; flavor synergies in complex food matrices remain unresolved; and consumer resistance to the "ultra-processed food" label. Future breakthroughs are likely to focus on three areas: 1. Using AI to predict the structure-activity relationship of sweetness molecules to accelerate the screening of new natural analogs; 2. Developing multi-functional compound sweeteners that combine sweetness with functionality (such as antioxidants and mineral carriers); and 3. Building digital models of "sweetness-metabolic health" to provide real-time intake recommendations for different populations.
In summary, the development of sweeteners has transcended simple taste simulation and has become an interdisciplinary field connecting food science, life sciences, and consumer health. As research deepens, it will find a better solution to meeting the global demand for sugar reduction while maintaining metabolic homeostasis, providing key support for building a sustainable dietary system.